Clinical Trials Browser

Phase 2 × Malignant Plasma Cell Neoplasms × 90 days × Clear all

NCT07560449 2026-05-01

QLS4131 Combination Therapy in Malignant Plasma Cell Neoplasms

Phase 2 Not yet recruiting

Malignant Plasma Cell Neoplasms